Journal article
Haplotype reference consortium panel: Practical implications of imputations with large reference panels
Adriana I Iglesias, Sven J van der Lee, Pieter WM Bonnemaijer, Rene Hoehn, Abhishek Nag, Puya Gharahkhani, Anthony P Khawaja, Linda Broer, Paul J Foster, Christopher J Hammond, Pirro G Hysi, Elisabeth M van Leeuwen, Stuart MacGregor, David A Mackey, Johanna Mazur, Stefan Nickels, Andre G Uitterlinden, Caroline CW Klaver, Najaf Amin, Cornelia M van Duijn
Human Mutation | WILEY | Published : 2017
DOI: 10.1002/humu.23247
Grants
Awarded by Netherlands Organization of Scientific Research NWO Investments
Awarded by Research Institute for Diseases in the Elderly
Awarded by Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA)
Awarded by European Commission FP6 STRP
Awarded by European Commission under the program 'Quality of Life and Management of the Living Resources' of the 5th Framework Programme
Awarded by National Institute of Health (NIH), National Eye Institute (NEI)
Funding Acknowledgements
Contract grant sponsors: Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands; Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); the Municipality of Rotterdam; the Netherlands Organization of Scientific Research NWO Investments (175.010.2005.011, 911-03-012); the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC; the Research Institute for Diseases in the Elderly (014-93-015; RIDE2); the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA) (050-060-810); the Genetic Laboratory of the Department of Internal Medicine; the Department of Forensic Molecular Biology; the Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands; European Commission FP6 STRP (018947) (LSHG-CT-2006-01947); the European Community's Seventh Framework Programme (FP7/2007-2013); the European Commission under the program 'Quality of Life and Management of the Living Resources' of the 5th Framework Programme (HEALTH-F4-2007-201413) (number QLG2-CT-2002-01254); Stichting Lijf en Leven; Stichting Oogfonds Nederland; Landelijke Stichting voor Blinden en Slechtzienden; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Medical Workshop; Heidelberg Engineering; Topcon Europe BV; Australian Research Council Future Fellowship; National Institute of Health (NIH), National Eye Institute (NEI), (1 R01 EY024233-03).